Primary antibodies used were COX-2, to differentiate osteoblastoma from low-grade osteosarcoma and Collagen I, to confirm osteoid matrix production and therefore osseous origin of the neoplasia. The gene discussed is PTGS2; the disease is Osteoblastoma.